Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.

All News

Neurocare Group Receives FDA Clearance for Its Industry-Leading Intermittent Theta Burst Stimulation (iTBS) Protocol for Transcranial Magnetic Stimulation (TMS)
Healthcare & PharmaceuticalProduct Announcements

Neurocare Group Receives FDA Clearance for Its Industry-Leading Intermittent Theta Burst Stimulation (iTBS) Protocol for Transcranial Magnetic Stimulation (TMS)

August 22, 2024 11:00 AM

neurocare is pleased to announce that it has received FDA clearance for its industry-leading intermittent Theta Burst Stimulation (iTBS) protocol, available across its Apollo TMS Therapy System and other Transcranial Magnetic Stimulation systems for clinical practice.ATLANTA, GA / ACCESSWIRE / August 22, 2024 / neurocare group ("neurocare" or the "Company"), a leading innovator in personalized mental health and performance, is pleased to...

Read more
In Pursuit of Excellence: State of the Art Electronic Consent for Clinical Trials
Healthcare & PharmaceuticalProduct Announcements

In Pursuit of Excellence: State of the Art Electronic Consent for Clinical Trials

August 22, 2024 11:00 AM

Protecting patients' rights and safety in Clinical Trial enrollmentFREMONT, CA / ACCESSWIRE / August 22, 2024 / CliniOps, Inc., a premier technology, and data science company for the life science industry, has relaunched its state-of-the-art electronic informed consent (eConsent) module. With this advanced eConsent, stakeholders from pharmaceutical companies, Clinical Research Organizations (CROs), Investigators, and site staff can educate and...

Read more
Stemtech Expands Into The $303 Billion Pet Health Care Market With Launch Of Stempets(TM)
Healthcare & PharmaceuticalProduct Announcements

Stemtech Expands Into The $303 Billion Pet Health Care Market With Launch Of Stempets(TM)

August 22, 2024 9:45 AM

Stemtech Corporation (OTCQB;STEK), a leader in the development and distribution of stemceutical™ products for humans offered since 2005, is proud to announce an exciting new product line into the pet health care industry with the launch of "StemPets™." This revolutionary product is designed to provide substantial health benefits to dogs, cats, and other beloved pets, tapping into the $303 billion pet health care market.Recognizing the profound...

Read more
Positive 8-Week Body Weight Results from Lexaria's GLP-1 Diabetes Animal Study
Healthcare & PharmaceuticalCompany Update

Positive 8-Week Body Weight Results from Lexaria's GLP-1 Diabetes Animal Study

August 22, 2024 9:20 AM

KELOWNA, BC / ACCESSWIRE / August 22, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that it has received and can now report on 8-week body weight results from ongoing animal study WEIGHT-A24-1 (the "Study").This Study is the only study carried out anywhere in the world today, to evaluate the relative performance of liraglutide processed with...

Read more
CNS Pharmaceuticals to Participate in Virtual Investor CEO Connect Segment
Healthcare & PharmaceuticalConferences

CNS Pharmaceuticals to Participate in Virtual Investor CEO Connect Segment

August 22, 2024 9:15 AM

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that John Climaco, Chief Executive Officer of CNS Pharmaceuticals will participate in a Virtual Investor CEO Connect segment on Monday, August 26, 2024 at 12:00 PM ET.As part of the virtual event, Mr. Climaco...

Read more
Aspen Dental: What to Expect During These 5 Common Dental Procedures in Allentown
Healthcare & PharmaceuticalCompany Update

Aspen Dental: What to Expect During These 5 Common Dental Procedures in Allentown

August 22, 2024 9:00 AM

When it comes to dental care, understanding what to expect can ease anxiety and ensure better outcomes. Whether it's a routine check-up or a more involved treatment, being informed about the process helps patients feel more in control. A dentist in Allentown, PA, can guide patients through their dental procedure before it starts. Here's what to expect before the following common dental procedures:1. Routine dental check-upsA routine dental...

Read more
Transforming Daily Lives Through Digital Savings
Healthcare & PharmaceuticalDiversity, Equity and Inclusion

Transforming Daily Lives Through Digital Savings

August 22, 2024 9:00 AM

NORTHAMPTON, MA / ACCESSWIRE / August 14, 2024 / CARE In Sierra Leone, small savings groups have a long history of supporting farmers and marginalized communities, especially women. In short, saving groups have transformed lives, offering financial support and fostering community resilience.Through increased access and control over resources, saving group members can financially empower their families and communities. CARE's engagement with...

Read more
KindlyMD(TM) Appoints Nancy Pratt as Behavioral Health Program Director
Healthcare & PharmaceuticalManagement Changes

KindlyMD(TM) Appoints Nancy Pratt as Behavioral Health Program Director

August 22, 2024 9:00 AM

KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, is pleased to announce the appointment of Nancy Pratt, a clinical mental health counselor (CMHC), as Behavioral Health Program Director.Ms. Pratt will bolster the KindlyMD leadership team, driving the...

Read more
Xcelerate, Inc. Announces Commencement of the Nationalization Process for its PCT International Patent Applications
Healthcare & PharmaceuticalCompany Update

Xcelerate, Inc. Announces Commencement of the Nationalization Process for its PCT International Patent Applications

August 22, 2024 8:05 AM

MAULDIN, SC / ACCESSWIRE / August 22, 2024 / Xcelerate, Inc. (OTCQB:"XCRT") today announced the commencement of the nationalization process for its two PCT international patent applications, PCT/US2023/015755 and PCT/US2023/016194. These international patents correspond to the US utility patent applications US 18/187,352 and US 18/189,441 filed with the United States Patent and Trademark Office (USPTO). The key innovation provided by these...

Read more
Moderna to Host Investor Event - R&D Day and Business Updates
Healthcare & PharmaceuticalCompany Update

Moderna to Host Investor Event - R&D Day and Business Updates

August 22, 2024 7:00 AM

Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its Investor Event - R&D Day and Business Updates at 9:00 a.m. ET on Thursday, September 12, 2024.The event will include presentations from management discussing Moderna's development and commercial strategy and key business considerations. A live webcast of the presentation will be available under "Events and Presentations" in the Investors section of the Moderna website at...

Read more
Zomedica Introduces Enhanced Audio Features for the VETGuardian(R) Zero-touch Vital Signs Remote Monitoring System
Healthcare & PharmaceuticalCompany Update

Zomedica Introduces Enhanced Audio Features for the VETGuardian(R) Zero-touch Vital Signs Remote Monitoring System

August 22, 2024 6:30 AM

ANN ARBOR, MI / ACCESSWIRE / August 22, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company", a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, announced the introduction of advanced audio capabilities for its VETGuardian Zero-touch remote vital signs monitoring system, poised to revolutionize remote patient monitoring in veterinary medicine. These...

Read more
Bioz and Spirochrome Forge Partnership to Enhance Research Discovery With Advanced Scientific Video Content
Healthcare & PharmaceuticalPartnerships

Bioz and Spirochrome Forge Partnership to Enhance Research Discovery With Advanced Scientific Video Content

August 22, 2024 4:00 AM

PALO ALTO, CA / ACCESSWIRE / August 22, 2024 / Bioz, Inc., a pioneer in AI-driven research solutions, is thrilled to unveil a new strategic alliance with Spirochrome, a leading innovator in fluorescence bioimaging technologies. This partnership is set to transform how researchers discover and engage with Spirochrome's advanced product offerings.Bioz Prime Badge Bioz Prime Badge With Video on Spirochrome's Website Bioz will integrate its...

Read more
Q2 Interim Report April-June 2024
Healthcare & PharmaceuticalEarnings

Q2 Interim Report April-June 2024

August 22, 2024 2:30 AM

STOCKHOLM, SE / ACCESSWIRE / August 22, 2024 / PMD Device Solutions (FRA:8T0) (STO:PMDS) Press release: Stockholm, 22 August 2024. PMD Device Solutions AB's (PMDS) interim report for April - June 2024 is now available on the company's website, www.pmd-solutions.com. Financial information April - June 2024 (figures in brackets relate to the same period in Q2 2023)Consolidated net sales for the three months are in line with expectations at kSEK...

Read more
MENA Syringes & Cannula Market Is Expected to Reach USD 2,824.7 Million by 2034 And Grow at A Compound Annual Growth Rate of 5.9 % | FMI Inc.
Healthcare & PharmaceuticalCompany Update

MENA Syringes & Cannula Market Is Expected to Reach USD 2,824.7 Million by 2034 And Grow at A Compound Annual Growth Rate of 5.9 % | FMI Inc.

August 22, 2024 2:30 AM

The MENA Syringes & Cannula Market is set for substantial growth, with sales expected to increase from USD 1,592.2 million in 2024 to USD 2,824.7 million by 2034. The market is projected to expand at a compound annual growth rate (CAGR) of 5.9% over the forecast period from 2024 to 2034.In 2023, the revenue generated by syringes alone was USD 1,108.1 million. The industry is anticipated to exhibit a year-over-year growth rate of 5.9% in 2024,...

Read more
Angle PLC - Data Supporting FDA Approval Published in Journal
Healthcare & PharmaceuticalRegulatory

Angle PLC - Data Supporting FDA Approval Published in Journal

August 22, 2024 2:00 AM

ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, is pleased to announce the publication of one of the Company's clinical studies that was submitted to the FDA for De Novo regulatory clearance of the Parsortix® PC1 system.This study, undertaken at ANGLE's UK laboratory, the University of Rochester, US, and...

Read more
Women in War
Healthcare & PharmaceuticalEnvironmental, Social and Governance

Women in War

August 21, 2024 6:55 PM

NORTHAMPTON, MA / ACCESSWIRE / August 21, 2024 / Women are the unsung heroes of crisis, yet they are grossly overlooked when it comes to dialogue and decision-making. After surveying more than 13,000 women in 15 countries since 2020, CARE found that 91% led or actively participated in community response. They provide meals and shelter, advocate for change, and work to make communities safer by offering health services and diversifying incomes...

Read more
MMJ Biopharma Cultivation Exposes Biden Harris DEA Administrator's Hypocrisy
Healthcare & PharmaceuticalCompany Update

MMJ Biopharma Cultivation Exposes Biden Harris DEA Administrator's Hypocrisy

August 21, 2024 4:30 PM

WASHINGTON, D.C. / ACCESSWIRE / August 21, 2024 /DEA Administrator Under Fire: Hypocrisy and Hindrance in Marijuana and Psychedelic ResearchThe government's prosecution of MMJ BioPharma Cultivation highlights significant ambiguities in the Controlled Substances Act (CSA), President Biden's Medical Marijuana and Cannabidiol Research Expansion Act, and the DEA's own regulatory standards. A critical point of contention is the legislation's...

Read more
Green Label RX Opens Its First Social-Equity Cannabis Retail Location In Canoga Park
Healthcare & PharmaceuticalCompany Update

Green Label RX Opens Its First Social-Equity Cannabis Retail Location In Canoga Park

August 21, 2024 3:45 PM

Green Label Rx, a pioneering force in the cannabis industry, proudly announces the grand opening of its first retail location in Canoga Park on Saturday, August 24. This milestone marks the culmination of a 25-year journey for founder Jason McKnight, a legacy operator, and social equity license holder, and the final step in creating a completely vertical seed-to-sale cannabis company. With over two decades of experience, McKnight and his wife...

Read more
My Quest Story - Pat Beall
Healthcare & PharmaceuticalEnvironmental, Social and Governance

My Quest Story - Pat Beall

August 21, 2024 1:45 PM

NORTHAMPTON, MA / ACCESSWIRE / August 21, 2024 / I only wish I had started my career at Quest about 10 years earlier. I was looking for a new job when I saw a medical courier for SmithKline Beecham Clinical Laboratories (SBCL) come into a doctor's office where I was a patient. Who knew that it would lead me to my career, which would turn into now 32 years in the medical service profession!I started my journey with our company as a route service...

Read more
Dental Sutures Market Set for Robust Growth is Projected to Reach USD 970.9 Million by 2034 | Future Market Insights, Inc.
Healthcare & PharmaceuticalCompany Update

Dental Sutures Market Set for Robust Growth is Projected to Reach USD 970.9 Million by 2034 | Future Market Insights, Inc.

August 21, 2024 1:00 PM

The global dental sutures market is on a strong growth trajectory, with sales estimated to reach USD 537.1 million in 2024 and projected to nearly double, hitting USD 970.9 million by 2034. This represents a compound annual growth rate (CAGR) of 6.10% over the forecast period. In 2023, the industry generated USD 506.2 million in revenue and is expected to exhibit a year-over-year growth of 6.1% in 2024.Dental sutures play a crucial role in...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?